Gastroesophageal Reflux Disease and Obesity
Abstract
The global rise of gastroesophageal reflux disease (GERD) prevalence makes it one of the most common diagnoses performed in a daily practice. Obesity significantly contribute to GERD development, accordingly, it has accounted for the increasing cases of GERD. Obesity can disrupt the esophagogastric junction integrity, which promote the development of GERD and its complication. The frequency of GERD symptoms and its mucosal complications also found more often in obesity. The parallel increase of both condition has initiated numerous studies to determine the most beneficial therapeutic options in managing this challenging condition. Current available therapy for GERD in obesity including weight reduction, pharmacotherapy, and surgery.
Read the paper
Related studies
- Advantages and Disadvantages of Long-term Proton Pump Inhibitor Use
- Ivth brazilian consensus conference on helicobacter pylori infection
- A pSMAD/CDX2 complex is essential for the intestinalization of epithelial metaplasia
- S2k-Leitlinie Gastroösophageale Refluxkrankheit und eosinophile Ösophagitis der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – März 2023 – AWMF-Registernummer: 021–013
- Step-by-step management of refractory gastresophageal reflux disease
- Insights into Effects/Risks of Chronic Hypergastrinemia and Lifelong PPI Treatment in Man Based on Studies of Patients with Zollinger–Ellison Syndrome
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.